Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMC 2022-04-01
Cyfres:Thrombosis Journal
Pynciau:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Mynediad Ar-lein:https://doi.org/10.1186/s12959-022-00380-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg